Skip to main content
GTHP
OTC Industrial Applications And Services

Guided Therapeutics Q3: $111K Cash, Going Concern, Material Weaknesses, New $0.20 Tranche

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$0.11
Mkt Cap
$10.619M
52W Low
$0.1
52W High
$0.54
52W Position info
10.0% above low
Off High info
80% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

GTHP is trading near its 52-week low of $0.1 (10.0% above the low) on light trading volume (0.1× avg).

Summary

Guided Therapeutics reported a $2.3 million nine-month loss with only $111 thousand of cash, reiterated going concern, disclosed material weaknesses in internal controls, and opened a new $0.20 per unit private placement tranche while its $1.1 million convertible debenture remains in default.


Key Events · Earnings and Guidance · GTHP

  • Q3 Loss and Thin Cash Balance

    Net loss attributable to common stockholders was $2.3 million for the nine months ended September 30, 2026, with cash of only $111 thousand versus a working capital deficit of approximately $6.2 million.

  • Going Concern Reiterated

    Accumulated deficit reached $159.4 million and stockholders' deficit $6.1 million; management states substantial doubt about the ability to continue as a going concern and may curtail operations or liquidate if capital cannot be raised.

  • Material Weaknesses Disclosed

    Disclosure controls were ineffective at September 30, 2026 due to material weaknesses from insufficient resources for complex transactions and lack of board/audit committee oversight, including documented approval of related-party transactions.

  • Debenture Still in Default

    The $1.1 million 10% senior convertible debenture matured May 17, 2024 and remains unpaid, accruing 18% default interest; total arrearage was about $1.4 million including $258 thousand of accrued interest.


Analysis · GTHP · Industrial Applications And Services

Guided Therapeutics ended September 30, 2026 with just $111 thousand of cash against a $6.2 million working capital deficit and a $159.4 million accumulated deficit, and management again states substantial doubt about its ability to continue as a going concern. The company also disclosed that its disclosure controls were ineffective because of material weaknesses in internal control over financial reporting, including a lack of board and audit committee oversight of significant and related-party transactions. Funding is coming from a rolling private placement: $480 thousand raised in the first nine months, a new $0.20 per unit tranche (up to 5,000,000 shares plus 7,500,000 warrants) that had drawn $100 thousand, and post-quarter subscriptions of $150 thousand plus a $500 thousand subscription that had not yet closed. Against that, the $1.1 million 10% convertible debenture has been in default since May 17, 2024 and now accrues 18% interest, with total arrearage of about $1.4 million. The FDA PMA clinical module was filed June 15, 2026 and the $145 thousand small-business user fee was paid September 28, 2026, so an FDA decision is the main swing factor; without new capital the company says it may have to curtail operations or liquidate.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GTHP was trading at $0.11 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $10.6M. The 52-week trading range was $0.10 to $0.54. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GTHP - Latest Insights

GTHP
Aug 13, 2026, 12:46 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.290
Real-time Price: $0.110 info
Change: -$0.180 (-62%) info
Market Cap: $10.619M info
GTHP
May 15, 2026, 1:21 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.200
Real-time Price: $0.110 info
Change: -$0.090 (-45%) info
Market Cap: $10.619M info
GTHP
May 15, 2026, 1:17 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.200
Real-time Price: $0.110 info
Change: -$0.090 (-45%) info
Market Cap: $10.619M info
GTHP
May 05, 2026, 6:21 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.200
Real-time Price: $0.110 info
Change: -$0.090 (-45%) info
Market Cap: $10.619M info
GTHP
Mar 31, 2026, 6:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.2464
Real-time Price: $0.110 info
Change: -$0.1364 (-55%) info
Market Cap: $10.619M info